Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 8, 2001, Pages 808-816

  Dong, Shu Min ^a   Pang, Jesse Chung Sean ^a   Poon, Wai Sang ^a   Hu, Jie ^b   To, Ka Fai ^a   Chang, Alexander Russell ^a   Ng, Ho Keung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

Author keywords

CpG islands; Methylation; O6 methylguanine DNA methyltransferase; Oligoastrocytoma; Oligodendroglioma; p73

Indexed keywords

DNA METHYLTRANSFERASE; DNA MINISATELLITE; GLUTATHIONE TRANSFERASE; PROTEIN KINASE; PROTEIN P16;

ARTICLE; CANCER GRADING; CHROMOSOME 19Q; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; METHYLATION; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0034925182     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.8.808     Document Type: Article

References (45)

1. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroglioma
2. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
3. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma
4. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
5. Cancer epigenetic comes of age
6. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
7. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma
8. Extensive DNA methylation spanning the Rb promotor in retinoblastoma tumors
9. 6-methylguanine-DNA methyltransferase by promotor hypermethylation is a common event in primary human neoplasia
10. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
11. Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction
12. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island
13. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
14. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation
15. Inactivation of glutathione S-transferase P1 gene by promotor hypermethylation in human neoplasia
16. Incidence and functional consequences of hMLH1 promotor methylation in colorectal carcinoma
17. ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
18. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors
19. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma
20. Promoter hypermethylation of the RB1 gene in glioblastomas
21. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia
22. CpG island methylator phenotype in colorectal cancer
23. Concordant methylation of the ER and N33 genes in glioblastoma multiforme
24. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
25. Hypermethylation of multiple genes in pancreatic adenocarcinoma
26. Progressive increases in de novo methylation of CpG islands in bladder cancer
27. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response to oligodendrogliomas and astrocytomas to chemotherapy
28. Inactivation of the DNA repair gene MGMT and the clinical response of gliomas to alkylating agents
29. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
30. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
31. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 parm deletions
32. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
33. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors
34. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
35. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
36. DAP kinase links the control of apoptosis to metastasis
37. Hypermethylation of the deathassociated protein (DAP) kinase promotor and aggressiveness in stage I non-small-cell lung cancer
38. Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview
39. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor
40. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
41. Infrequent methylation of CDKN2A(MST1/p16) and rare mutation of both CDKN2A and CDKN2B(MST2/p15) in primary astrocytic tumours
42. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas
43. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B